GE, Cardinal Accused Of Manipulating Cardiac Imaging Market

Law360, New York (March 27, 2012, 10:25 PM EDT) -- A California nuclear pharmacy on Monday filed a putative class action against GE Healthcare Inc. and Cardinal Health Inc., alleging the companies conspired to keep prices for their cardiac imaging agents high by refusing to sell them to independent pharmacies.

In a complaint filed in California federal court, PharmaRx Pharmaceutical Inc. claims GE refused to sell Myoview and other GE proprietary products to independent nuclear pharmacies, or radiopharmacies, in areas where there was already a GE-operated radiopharmacy.

And after a 2008 agreement made to allegedly keep...
To view the full article, register now.